C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.26
C12N 15/00 (2006.01) A61K 39/245 (2006.01) C12N 7/00 (2006.01)
Patent
CA 1280986
THYMIDINE KINASE DELETION MUTANTS OF BOVINE HERPESVIRUS-1, VACCINES AGAINST INFECTIOUS BOVINE RHINOTRACHEITIS CONTAINING SAME AND METHODS FOR THE PRODUCTION AND USE OF SAME ABSTRACT OF THE DISCLOSURE Bovine herpesvirus type 1 (infectious bovine rhinotracheitis virus) mutants which fail to produce any functional thymidine kinase as a result of a deletion in the thymidine kinase gene. The deletion in the thymidine kinase gene attenuates the viruses so that they can be used as an active agent in a modified live-virus vaccine against infectious bovine rhino- tracheitis. This invention also relates to methods for the production and use of the same.
521529
Kit Malon
Kit Saul
Baylor College Of Medicine
G. Ronald Bell & Associates
Novagene Inc.
LandOfFree
Thymidine kinase deletion mutants of bovine herpesvirus-1,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thymidine kinase deletion mutants of bovine herpesvirus-1,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymidine kinase deletion mutants of bovine herpesvirus-1,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1219860